A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

Clinical trial NCT07358546 · RECRUITING

Trial details

NCT number: NCT07358546
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-alcoholic Fatty Liver Disease

Start date: 2026-03-13
Primary completion: 2027-10-13
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.